Medartis Holding AG / Key word(s): Personnel
11-Dec-2020 / 06:59 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
Medartis Holding AG
Medartis appoints Dirk Kirsten as Chief Financial Officer
Basel, Switzerland, 11 December 2020 – The Board of Directors of Medartis Holding AG (SIX: MED) has appointed Dirk Kirsten as new Chief Financial Officer and Member of the Executive Management Board. He will join Medartis as of 1 march 2021 and will succeed Dominique Leutwyler, who has decided to leave the company.
In his future role as CFO and Member of the Executive Management Board of Medartis, Dirk Kirsten will be responsible for all matters of internal and external group financial management, as well as for the group’s M&A projects, thus actively supporting further growth and envisaged portfolio expansions.
As a proven financial expert with broad industry experience, Dirk Kirsten (1968) has a strong track record in international management, corporate finance and M&A and held various senior management positions in the medtech, pharmaceutical and healthcare sectors. These included the roles as CFO of Nobel Biocare (2008-2013), Group Treasurer of Syngenta (2004-2008) and Head Group Funding & Capital Markets of Roche Holding (2002-2004). Prior to that, he worked with global investment banks, where he specialized in healthcare transactions. In 2013, Dirk Kirsten founded his own advisory boutique focusing on M&A, private equity as well as start-up financing and business development. Dirk Kirsten is a Swiss and German citizen. He holds a PhD in Management & Economics from the University of Cologne and participated in the international MBA program of the London Business School.
Over the last 20 years, Dominique Leutwyler has made a significant contribution as CFO in building the pillars of Medartis on its way from a start-up to a listed company with broad international presence. He established and further developed the group’s finance functions, supply chain and ICT operations and was additionally responsible for the set-up of its production infrastructure and its thirteen subsidiaries as well as for various beneficial M&A activities. He also lead-managed Medartis’ successful IPO in 2018. He will remain in his position until the 2020 full-year results publication on 10 March 2021. The Board of Directors and Executive Management Board regret Dominique Leutwyler’s decision and are grateful to him for his extensive and successful contributions in building Medartis to its current strengths. Medartis wishes him every success for his future.
End of ad hoc announcement
|Company:||Medartis Holding AG|
|Phone:||+41 61 633 34 34|
|Fax:||+41 61 633 34 00|
|Listed:||SIX Swiss Exchange|
|EQS News ID:||1154353|
|End of Announcement||EQS Group News Service|